Comparative study of actinic keratosis treatment with 3% diclofenac sodium and 5% 5-fluorouracil;Estudo comparativo do tratamento de ceratoses actínicas com diclofenaco sódico 3% e 5-fluorouracil 5%

Anais Brasileiros de Dermatologia

Volumn 88, Issue 5, 2013, Pages 732-738

  Segatto, Majoriê Mergen ^a   Dornelles, Sérgio Ivan Torres ^b   Silveira, Vera Bauer ^c   Frantz, Gabriela de Oliveira ^d  

^a UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Sanitary Dermatology   (Brazil)

^d NONE

Author keywords

Actinic; Diclofenac; Fluorouracil; Keratosis; Therapeutics

Indexed keywords

DICLOFENAC; FLUOROURACIL;

ACTINIC KERATOSIS; ADULT; AGED; APPLICATION SITE DESQUAMATION; ARTICLE; CLINICAL ARTICLE; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG TOLERABILITY; DRY SKIN; EDEMA; ERYTHEMA; FEMALE; HUMAN; MALE; PAIN; PATIENT SATISFACTION; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SKIN DEFECT; SKIN DISCOMFORT; TREATMENT RESPONSE; XEROSIS;

ADMINISTRATION, CUTANEOUS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; DERMATOLOGIC AGENTS; DICLOFENAC; FEMALE; FLUOROURACIL; HUMANS; KERATOSIS, ACTINIC; MALE; MIDDLE AGED; PATIENT SATISFACTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84891871272     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/abd1806-4841.20132083     Document Type: Article

References (23)

1. Ramos e Silva M, Castro MCR. Fundamentos de dermatologia. 1 ed. São Paulo: Ateneu; 2009.
2. Salache SJ. Epidemiology of actinic keratoses and squamous cell carcinoma. J Am Acad Dermatol. 2000;42:4-7.
3. Sociedade Brasileira de Dermatologia. Nosologic profile of dermatologic visits in Brazil. An Bras Dermatol. 2006;81:545-54.
4. Gupta AK, Cooper EA, Feldman SR, Fleischer AB Jr. A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey. Cutis. 2002;70:S8-13.
5. Marks R, Rennie G, Selwood TS. Malignant transformation of solar keratoses to squamous cell carcinoma. Lancet. 1988;1:795-7.
6. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Rio de Janeiro: Elsevier; 2008.
7. Hurwitz RM, Monger LE. Solar keratosis: an evolving squamous cell carcinoma: Benign or malignant? Dermatol Surg. 1995;21:184.
8. Gold MH, Nestor MS. Current treatments of actinic keratosis. J Drugs Dermatol. 2006;5:17-25
9. Rapini RP. Dermatopatologia prática. Rio de Janeiro: Di Livros; 2007.
10. McIntyre WJ, Downs MR, Bedwell SA. Treatment options for actinic keratoses. Am Fam Physician. 2007;76:667-71.
11. Del Rosso JQ. New and emerging topical approaches for actinic keratoses. Cutis. 2003;72:273-6, 279.
12. Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J. Topical therapy for actinic keratoses, I: 5-fluorouracil and imiquimod. Cutis. 2003;71:365-70.
13. Stockfleth E, Kerl H; Guideline Subcommittee of the European Dermatology Forum. Guidelines for the management of actinic keratoses. Eur J Dermatol. 2006;16:599-606.
14. Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J. Topical therapy for actinic keratoses, II: Diclofenac, colchicine, and retinoids. Cutis. 2003;71:373-9.
15. Berman B, Cohen DE, Amini S. What is the role of field-directed therapy in the treatment of actinic keratosis? Part 1: overview and investigational topical agents. Cutis. 2012;89:241-50.
16. de Berker D, McGregor JM, Hughes BR; British Association of Dermatologists Therapy Guidelines and Audit Subcommittee. Guidelines for the management of actinic keratoses. Br J Dermatol. 2007;156:222-30.
17. Krawtchenko N, Roewert-Huber J, Ulrich M, Mann I, Sterry W, Stockfleth E. A randomised study of topical imiquimod vs. topical 5-fluoracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up. Br J Dermatol. 2007;157:34-40.
18. Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis--a systematic review of randomized controlled trials. Int J Dermatol. 2009;48:453-63.
19. Gebauer K, Brown P, Varigos G. Topical diclofenac in hyaluronan gel for the treatment of solar keratoses. Australes J Dermatol. 2003;44:40-3.
20. Fariba I, Ali A, Hossein SA, Atefeh S, Atarzadeh Behbahan SA. Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: A randomized, double-blind, placebo controlled study. Indian J Dermatol Venereol Leprol. 2006;72:346-9.
21. Smith SR, Morhenn VB, Piacquadio DJ. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp. J Drugs Dermatol. 2006;5:156-9.
22. Kose O, Koc E, Erbil AH, Caliskan E, Kurumlu Z. Comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% imiquimod cream in the treatment of actinic keratosis. J Dermatolog Treat. 2008;19:159-63.
23. Akarsu S, Aktan S, Atahan A, Koç P, Özkan S. Comparison of topical 3% diclofenac sodium gel and 5% imiquimod cream for the treatment of actinic keratoses. Clin Exp Dermatol. 2011;36:479-84.